Sterile Tubing Welder Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Sterile Tubing Welder Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Sterile Tubing Welder Market is expected to register a CAGR of 4% during the forecast period. This is attributing to increasing R&D expenditure, growing demand across hospitals and research clinics. In addition, the rising adoption of Single-use technologies and increasing demand for blood and blood products are also fueling the revenue growth of the market. As these sterile tubings are welders are important processes in because sterile transfers play a major role in various areas such as blood processing, biopharmaceuticals etc. thus results in propelling the market. According to a report published by the National Institute of Health (NIH), an estimate of 85 million units is transfused (blood transfusion) globally. These are transfused for the treatment of hematologic disorders such as anemia, leukemia, sickle cell diseases. With such a huge number of transfusions taking place results in high demand and adoption of blood products thus promoting the growth of the overall market. Moreover, contamination of blood results in wastage, improper storage, lack of proper handling associated with blood processing is some more factors that are boosting the demand of automated sterile tubing welder and further drive the market.

Key Market TrendsSterile Tubing Welder in Blood Processing is Estimated to Witness a Healthy Growth in Future.

Sterile tubing welder in blood processing is estimated to witness a healthy growth in the future attributing to the high demand for personalized medicines, increasing prevalence of blood disorders, rising demand for blood and blood products and increasing cell and gene therapy. As per the World Federation of Hemophilia, in 2018 around 210,454 people had experienced hemophilia results in boosting the demand for Sterile tubing welder Market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global Sterile Tubing Welder Market due to the increasing demand for a hygienic and sterile environment, rising prevalence of chronic diseases, technological advancements, healthcare expenditure and presence of well-established healthcare infrastructure. As per the American Red Cross, an estimate of 36000 units of red blood cells is needed every day and around 21 million blood components are transfused each year in the United States. Thus surge the demand for blood transfusion in the United States and promotes the growth of the sterile tubing market in this region.

Competitive Landscape

The Sterile Tubing Welder Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Cytiva (GE Healthcare), TERUMO BCT, INC., Genesis BPS, MGA Technologies, SARTORIUS AG, Entegris, Inc., BIOMEN BIOSYSTEMS COMPANY LIMITED, and Vante Biopharm / Sebra.

Additional Benefits:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Companies Mentioned
 
Cytiva (GE Healthcare)
TERUMO BCT, INC.
Genesis BPS
MGA Technologies
SARTORIUS AG
Entegris, Inc.
BIOMEN BIOSYSTEMS COMPANY LIMITED
Vante Biopharm / Sebra

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.


1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing R&D Expenditure
4.2.2 Growing Demand across Hospitals and Research Clinics
4.3 Market Restraints
4.3.1 Presence of Alternatives
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Mode
5.1.1 Automatic
5.1.2 Manual
5.2 By Applications
5.2.1 Blood Processing
5.2.2 Biopharmaceuticals
5.2.3 Diagnostic Laboratories
5.2.4 Others
5.3 By End Users
5.3.1 Hospitals
5.3.2 Research Clinics
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Cytiva (GE Healthcare)
6.1.2 TERUMO BCT, INC.
6.1.3 Genesis BPS
6.1.4 MGA Technologies
6.1.5 SARTORIUS AG
6.1.6 Entegris, Inc.
6.1.7 BIOMEN BIOSYSTEMS COMPANY LIMITED
6.1.8 Vante Biopharm / Sebra
7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings